PHARMACOLOGICAL PROFILE OF DA-8010, A NOVEL BLADDER SELECTIVE MUSCARINIC RECEPTOR 3 ANTAGONIST FOR TREATMENT OF OVERACTIVE BLADDER

被引：0
|
作者：
Lee, Min Jung
Moon, Jun-Hwan
Park, Hyun-Min
Lee, Hyung Keun
Cho, Jong Hwan
Choi, Sung Hak
Im, Weonbin
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.1247
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP30-15
引用
收藏
页码：E416 / E417
页数：2
相关论文
共 50 条
  • [1] The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction
    Jin Bong Choi
    Seung Hwan Jeon
    Eun Bi Kwon
    Woong Jin Bae
    Hyuk Jin Cho
    U-Syn Ha
    Sung-Hoo Hong
    Ji Youl Lee
    Sae Woong Kim
    BMC Urology, 20
  • [2] Pharmacological characterization of DA-8010, a novel muscarinic receptor antagonist selective for urinary bladder over salivary gland
    Lee, Min Jung
    Moon, Jun-Hwan
    Lee, Hyung Keun
    Cho, Chong Hwan
    Choi, Sung Hak
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 843 : 240 - 250
  • [3] The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction
    Choi, Jin Bong
    Jeon, Seung Hwan
    Kwon, Eun Bi
    Bae, Woong Jin
    Cho, Hyuk Jin
    Ha, U-Syn
    Hong, Sung-Hoo
    Lee, Ji Youl
    Kim, Sae Woong
    BMC UROLOGY, 2020, 20 (01)
  • [4] EFFECT OF FOOD ON PHARMACOKINETICS AND SAFETY OF DA-8010, A NOVEL SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS
    Khwarg, J.
    Yang, E.
    Chung, W.
    Park, S.
    Jang, I
    Cho, J.
    Ryu, C.
    Lee, D.
    Lee, M.
    Kim, H.
    Lee, S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S29 - S30
  • [5] Darifenacin:: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder
    Chapple, CR
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) : 1493 - 1500
  • [6] Darifenacin:: a muscarinic M3-selective receptor antagonist for the treatment of overactive bladder
    Zinner, Norman
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (04) : 511 - 523
  • [7] Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome
    Michel, Martin C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (10) : 1787 - 1796
  • [8] Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study
    Son, Hee Seo
    Oh, Cheol Young
    Choo, Myung-Soo
    Kim, Hyeong Gon
    Kim, Joon Chul
    Lee, Kyu-Sung
    Shin, Dong Gil
    Cho, Sung Yong
    Jeong, Seong Jin
    Seo, Ju Tae
    Yoon, Hana
    Moon, Hong Sang
    Kim, Jang Hwan
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2022, 26 (02) : 119 - 128
  • [9] AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder
    Sinha, S.
    Gupta, S.
    Malhotra, S.
    Krishna, N. S.
    Meru, A. V.
    Babu, V.
    Bansal, V.
    Garg, M.
    Kumar, N.
    Chugh, A.
    Ray, A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (05) : 1119 - 1127
  • [10] Darifenacin -: An M3-selective muscarinic antagonist for the treatment of overactive bladder
    Kirwin, JL
    FORMULARY, 2004, 39 (06) : 291 - +
12345